Most patients with diffuse large B‐cell lymphoma (DLBCL) are diagnosed at age 60 years or
older. Challenges to effective therapy among older individuals include unfavorable biologic …

Hematological malignancies require intensive and long-term treatment, which brings a
significant burden on patients, leading to unmet supportive care needs. The purpose of this …

Palliative care, hospice care, and end of life care have been the focus of increased attention
over the past two decades; palliative care has shifted from being introduced only at the end …

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy
worldwide, comprising approximately 30% of all lymphomas. Currently, 50% to 60% of …

Patients with hematologic malignancies (HM) nowadays rarely receive palliative or hospice
care, and studies on potential effects of integrated palliative care are rare. This narrative …

Background: The surprise question (SQ),“Would I be surprised if this patient died within one
year?”, is a simple instrument to identify patients with palliative care needs. The SQ …

Background: Early palliative care is increasingly used in solid organ malignancy but is less
established in patients with hematologic malignancy. Disease-related factors increase the …

Recent advances in treatment of patients with aggressive lymphomas ranging from chimeric
antigen receptor T-cell therapy to combination of antibody–drug conjugates with …

Abstract Purpose of Review The medical field has a critical role not only in prolonging life
but also in helping patients achieve a good death. Early studies assessing end-of-life quality …

The “surprise question”(SQ) predicts the need for palliative care. Its predictive validity for
adverse healthcare outcomes and its association with frailty among older people attending …